1
ION-682884 in Patients With TTR Amyloid Cardiomyopathy
Condition(s):Transthyretin Amyloid CardiopathyLast Updated:April 15, 2021Not yet recruiting
Transthyretin Amyloid Cardiopathy: 40 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis
Condition(s):Transthyretin Amyloid Cardiopathy; Mitochondrial PathologyLast Updated:January 27, 2023Recruiting
3
Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)
Condition(s):Transthyretin Amyloidosis; Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy; Transthyretin Amyloid CardiopathyLast Updated:February 10, 2023Withdrawn
4
TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
Condition(s):Transthyretin Amyloidosis; Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy; Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy; Polyneuropathies; CardiomyopathiesLast Updated:February 22, 2023Recruiting
5
A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis
Condition(s):Transthyretin Amyloid Cardiomyopathy (ATTR CM)Last Updated:January 31, 2023Recruiting
6
Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)
Condition(s):Wild-type Amyloid CardiopathyLast Updated:July 6, 2022Recruiting
7
High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac Amyloidosis
Condition(s):Cardiac Amyloidosis; Cardiac DiseaseLast Updated:July 9, 2021Not yet recruiting
8
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Condition(s):Amyloidosis; Amyloid Cardiomyopathy; Transthyretin Amyloidosis; Cardiomyopathies; Heart DiseasesLast Updated:December 30, 2021Active, not recruiting
9
The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart
Condition(s):AmyloidosisLast Updated:August 10, 2016Withdrawn
10
Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
Condition(s):Heart Disease; Aging; Amyloidosis; Aortic Valve StenosisLast Updated:October 3, 2022Active, not recruiting